Listed

NutriBand Inc.: Form 10-Q for the period ended Jul 31, 2022

Filed with the SEC on Sep 8, 2022 and accepted by EDGAR at Sep 7, 2022, 17:54 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-07-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-05-01 to 2022-07-31$456.1kus-gaap:Revenues
Revenue6 months2022-02-01 to 2022-07-31$934.1kus-gaap:Revenues
Cost of revenue3 months2022-05-01 to 2022-07-31$304.4kus-gaap:CostOfRevenue
Cost of revenue6 months2022-02-01 to 2022-07-31$581.8kus-gaap:CostOfRevenue
Gross profit3 months2022-05-01 to 2022-07-31$151.8kus-gaap:GrossProfit
Gross profit6 months2022-02-01 to 2022-07-31$352.3kus-gaap:GrossProfit
Selling, general and administrative3 months2022-05-01 to 2022-07-31$908.2kus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2022-02-01 to 2022-07-31$1.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-05-01 to 2022-07-31−$1.0mus-gaap:OperatingIncomeLoss
Operating income6 months2022-02-01 to 2022-07-31−$1.7mus-gaap:OperatingIncomeLoss
Net income3 months2022-05-01 to 2022-07-31−$1.0mus-gaap:NetIncomeLoss
Net income6 months2022-02-01 to 2022-07-31−$1.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-05-01 to 2022-07-31−$0.12us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2022-02-01 to 2022-07-31−$0.20us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-05-01 to 2022-07-31−$0.12us-gaap:EarningsPerShareBasic
Basic EPS6 months2022-02-01 to 2022-07-31−$0.20us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-05-01 to 2022-07-318,409,141 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2022-02-01 to 2022-07-318,779,933 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2022-02-01 to 2022-07-31−$1.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2022-02-01 to 2022-07-31$68.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2022-07-31$3.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-07-31$4.1mus-gaap:AssetsCurrent
Total assetsAt period end2022-07-31$11.4mus-gaap:Assets
Current liabilitiesAt period end2022-07-31$803.9kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-07-31$985.2kus-gaap:Liabilities
Shareholders' equityAt period end2022-07-31$10.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-22-054592. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.